Muroctasin, a muramyl dipeptide derivative
Sosnowska, D.; Dzierzbicka, K.; Myśliwski, A.; Kołodziejczyk, A.M.
Postepy Higieny i Medycyny Doswiadczalnej 46(5): 521-530
1992
ISSN/ISBN: 0032-5449 PMID: 1298958 Document Number: 389667
This paper presents a review of studies on the metabolism, pharmacological and clinical properties of a new synthetic muramyl dipeptide derivative N2-/(N-acetylmuramoyl)-L-alanyl-D-isoglutaminyl/-N6-stearoyl-L-lysine(MD P- Lys(L18), muroctasin). Due to its effect on the number of peripheral blood leukocytes this compound is expected to be a useful drug for the treatment of leukopenia induced by cancer chemotherapy or radiation therapy.
Document emailed within 1 workday
Related Documents
Fogler, W.E.; Wade, R.; Brundish, D.E.; Fidler, I.J. 1985: Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice Journal of Immunology 135(2): 1372-1377Horák, P.; Masek, K. 1988: Analgesic activity of two synthetic immunomodulators, muramyl dipeptide and adamantylamide dipeptide in mice and rats Methods and Findings in Experimental and Clinical Pharmacology 10(9): 569-574
Karsonova, M.I.; Andronova, T.M.; Pinegin, B.V.; Khaitov, R.M. 1999: The immunostimulating activity of muramyl dipeptide and its derivatives Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 104-110
Colover, J. 1984: Acute demyelination in EAE after pretreatment with foreign protein and muramyl dipeptide (MDP) Progress in Clinical and Biological Research 146: 37-42
Zouali, M.; Jolivet, M.; Leclerc, C.; Ravisse, P.; Audibert, F.; Eyquem, A.; Chedio, L. 1985: Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG Journal of Immunology 135(2): 1091-1096
Gupta, G.S.; Kinsky, R.G. 1994: Effects of immunization with sperm specific lactate dehydrogenase with and without muramyl dipeptide as adjuvant Indian Journal of Medical Research 100: 98-105
Souvannavong, V.; Adam, A. 1984: Restoration and stimulation of the in vitro immune response of B cells to sheep erythrocytes by interleukins and muramyl dipeptide (MDP) Biochemical and Biophysical Research Communications 125(1): 431-439
Parshykov, O.V.; Stefanov, O.V. 2009: Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages Ukrains'kyi Biokhimichnyi Zhurnal 81(5): 74-82
Schroit, A.J.; Fidler, I.J. 1982: Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide Cancer Research 42(1): 161-167
Fogler, W.E.; Fidler, I.J. 1986: The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction Journal of Immunology 136(6): 2311-2317
Fidler, I.J.; Fogler, W.E.; Brownbill, A.F.; Schumann, G. 1987: Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide Journal of Immunology 138(12): 4509-4514
Rojs, O.Z.; Cerne, M.; Mrzel, I.; Urleb, U.; Muraoka, S. 2000: Immunostimulatory effects of the muramyl dipeptide analogue LK415 in chickens immunized with a vaccine strain of infectious bursal disease virus Acta Veterinaria Hungarica 48(2): 237-248
Rakhmilevich, A.L.; Pelevina, M.A.; Artsimovich, N.G.; Fuks, B.B. 1988: The stimulating action of lipopolysaccharide and muramyl dipeptide on the activation of mononuclear cells in human peripheral blood by recombinant interleukin-2 in vitro Biulleten' Eksperimental'noi Biologii i Meditsiny 106(12): 698-701
Edwards, C.K.; Hedegaard, H.B.; Zlotnik, A.; Gangadharam, P.R.; Johnston, R.B.; Pabst, M.J. 1986: Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma Journal of Immunology 136(5): 1820-1827
Saxena, R.P.; Puri, A.; Saxena, K.C.; Shukla, R.; Haq, W.; Rizvi, S.Y.; Kundu, B.; Mathur, K.B. 1991: Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model Indian Journal of Experimental Biology 29(2): 111-115
Nĕmecková, S.; Bubeník, J.; Jezek, J.; Zaoral, M. 1982: Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide Folia Biologica 28(5): 327-333
Daemen, T.; Veninga, A.; Dijkstra, J.; Scherphof, G. 1989: Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes Journal of Immunology 142(7): 2469-2474
Saiki, I.; Fidler, I.J. 1985: Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages Journal of Immunology 135(1): 684-688
Utsugi, T.; Sone, S. 1986: Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes Journal of Immunology 136(3): 1117-1122
Urba, W.J.; Hartmann, L.C.; Longo, D.L.; Steis, R.G.; Smith, J.W.; Kedar, I.; Creekmore, S.; Sznol, M.; Conlon, K.; Kopp, W.C. 1990: Phase i and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamine Cancer Research 50(10): 2979-2986